White & Case Advises Banca Farmafactoring on €200 Million Notes Issuance
Global law firm White & Case LLP has advised Banca Farmafactoring S.p.A. on the issue of €200 million, two percent notes due 2022, issued pursuant to Regulation S under the Securities Act.
The Notes are listed on the Regulated Market of the Irish Stock Exchange.
Banca Farmafactoring specialises in the management, sale and non-recourse factoring of receivables owed to suppliers mainly by national healthcare service entities and other Italian public sector organisations.
White & Case advised on both English and Italian law aspects and the team was led by partners Michael Immordino (Milan & London) and Ferigo Foscari together with associates Louise Ruggiero and Davide Diverio (all Milan).
For more information please speak to your local media contact.